MTOR and malignant peripheral nerve sheath tumor: Malone et al. (2017) showed mTOR, and HDAC inhibitors kill aggressive malignancies of the nervous system, including MPNST, and cause tumors regression in vivo by converging on the TXNIP/thioredoxin antioxidant pathway through cooperative effects on chromatin and transcription [11].